Log in to your Inderes Free account to see all free content on this page.
Oriola
0.896
EUR
-0.99 %
Corporate customer
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
7,637 following
-0.99%
-5.29%
-2.5%
0%
-17.65%
-13.68%
-54.66%
-57.74%
-51.29%
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Read moreMarket cap
162.61M EUR
Turnover
115.36K EUR
P/E (adj.) (24e)
EV/EBIT (adj.) (24e)
P/B (24e)
EV/S (24e)
Dividend yield-% (24e)
Coverage
Financial calendar
4.3.
2025
Annual report '24
2.4.
2025
General meeting '24
29.4.
2025
Interim report Q1'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
Oriola Oyj: Oriola renews operating model and management team to accelerate strategy execution
Oriola Oyj: The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB's appeal regarding the sale of Svensk dos AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio